Skip to content
Menu

RBC Capital Maintains Outperform on Repligen, Raises Price Target to $200

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

RBC Capital analyst Dan Leonard maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target from $185 to $200.

RBC Capital analyst Dan Leonard maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target from $185 to $200.

Read at benzinga.com